Insurance Companies

UnitedHealth to Report Q2 Results as Options Price a Roughly 6% Post‑Earnings Move

Investor reaction will hinge on Optum margins, medical-cost trends, plus governance and legal risks that could validate or unsettle a 30% year-to-date rally.